More Options for Prelabor Rupture of Membranes, A Bayesian Analysis

Ashley Klein,Edward Raff,Elisabeth Seamon,Lily Foley,Timothy Bussert
2024-08-20
Abstract:An obstetric goal for a laboring mother is to achieve a vaginal delivery as it reduces the risks inherent in major abdominal surgery (i.e., a Cesarean section). Various medical interventions may be used by a physician to increase the likelihood of this occurring while minimizing maternal and fetal morbidity. However, patients with prelabor rupture of membranes (PROM) have only two commonly used options for cervical ripening, Pitocin and misoprostol. Little research exists on the benefits/risks for these two key drugs for PROM patients. A major limitation with most induction-of-labor related research is the inability to account for differences in \textit{Bishop scores} that are commonly used in obstetrical practice to determine the next induction agent offered to the patient. This creates a confounding factor, which biases the results, but has not been realized in the literature. In this work, we use a Bayesian model of the relationships between the relevant factors, informed by expert physicians, to separate the confounding variable from its actual impact. In doing so, we provide strong evidence that pitocin and buccal misoprostol are equally effective and safe; thus, physicians have more choice in clinical care than previously realized. This is particularly important for developing countries where neither medication may be readily available, and prior guidelines may create an artificial barrier to needed medication.
Applications,Machine Learning
What problem does this paper attempt to address?
The paper attempts to address whether the choice of cervical ripening agents in patients with premature rupture of membranes (PROM) is influenced by the Bishop score, thereby affecting the true assessment of drug efficacy and safety. Specifically, the study aims to re-evaluate the effectiveness and safety of Pitocin and buccal misoprostol in PROM patients by excluding the Bishop score as a confounding factor through Bayesian model analysis, providing more clinical options. ### Background and Importance of the Problem - **Background**: Clinically, premature rupture of membranes (PROM) refers to the rupture of the amniotic sac before the onset of labor, affecting approximately 8% of delivering mothers. For PROM patients, timely induction of labor can reduce the risk of intrauterine infection and other complications. However, the effectiveness and safety of the two main drugs used for cervical ripening—Pitocin and misoprostol—have not been fully studied. - **Problem**: Existing studies suggest that Pitocin is more effective than misoprostol, but these studies overlook the impact of the Bishop score on drug choice. The Bishop score is a commonly used clinical indicator to assess cervical ripeness and determine which induction drug to use. Due to the subjectivity and variability of the score, this selection method may introduce bias, leading to inaccurate assessments of drug efficacy. ### Research Objectives - **Primary Objective**: To re-evaluate the effectiveness and safety of Pitocin and buccal misoprostol in PROM patients by excluding the confounding influence of the Bishop score through Bayesian model analysis. - **Specific Objectives**: - Compare the induction time between Pitocin and buccal misoprostol in PROM patients. - Compare the cesarean section rates between the two drugs in PROM patients. - Evaluate other relevant clinical indicators in PROM patients, such as the number of examinations. ### Methods - **Data Source**: The study reviewed 7 years of patient records, totaling 82 cases of PROM patients. - **Model Construction**: A Bayesian hierarchical model was used to handle missing values and consider various clinical variables (such as components of the Bishop score, primiparous status, fetal growth restriction, etc.) affecting the induction outcome. - **Result Validation**: Posterior predictive checks were used to validate the model's fit to the observed data. ### Main Findings - **Induction Time**: There was no significant difference in induction time between Pitocin and buccal misoprostol. - **Cesarean Section Rate**: There was also no significant difference in cesarean section rates between the two drugs. - **Other Indicators**: Both drugs performed similarly in terms of the number of patient examinations and other clinical indicators. ### Conclusion - **Clinical Significance**: The study results indicate that Pitocin and buccal misoprostol have comparable effectiveness and safety in PROM patients. This provides clinicians with more options, especially in resource-limited developing countries where these drugs may not always be available, making this finding particularly important. - **Future Directions**: It is recommended to conduct randomized controlled trials (RCTs) to further validate this conclusion, providing stronger evidence to support clinical guidelines.